Memorial Sloan-Kettering Cancer Center

Memorial Sloan–Kettering Cancer Center (MSKCC) is a cancer treatment and research institution founded in 1884 as the New York Cancer Hospital. The main campus is located at 1275 York Avenue, between 67th and 68th Streets in New York City, with other locations in Basking Ridge, New Jersey, Long Island and Westchester County, New York. MSKCC is actually composed of two intimately related institutions. Memorial Hospital for Cancer and Allied Diseases, currently led by Physician-In-Chief, Dr. Robert Wittes, provides patient care, whose origins stemmed from a medical laboratory established on the campus of Cornell Medical Center and funded by John D. Rockefeller, in 1900. The original Memorial Hospital building was designed by Henry C. Pelton and constructed in 1939 by a group that included John J. Astor and his wife, Charlotte. Between 1970 and 1973 a new memorial hospital was built on the same site—originally donated by John D. Rockefeller, Jr. Sloan–Kettering Institute, currently led by Dr. Thomas Kelly, is MSKCC's basic-science research arm. The research institute was established in 1945 with a US$4 million gift from the foundation of Alfred P. Sloan, Jr.


Some content from Wikipedia, licensed under CC BY-SA

New monoclonal antibody developed that can target proteins inside cancer cells

Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since most proteins that cause cancer or are associated with cancer ...

Cancer created Mar 13, 2013 | popularity 5 / 5 (6) | comments 0 | with audio podcast

Drug shown to reverse radioiodine resistance in some advanced thyroid cancers

The experimental drug selumetinib may allow some patients with advanced thyroid cancer to overcome resistance to radioiodine (RAI), the most effective therapy for the disease, according to new research from Memorial Sloan-Kettering ...

Cancer created Feb 14, 2013 | popularity not rated yet | comments 0

Adoptive cell transfer: New technique could make cell-based immune therapies for cancer safer, more effective

A team led by Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at Memorial Sloan-Kettering Cancer Center, has shown for the first time the effectiveness of a new technique that could allow the development ...

Cancer created Dec 16, 2012 | popularity 5 / 5 (2) | comments 0 | with audio podcast

Testing for mutations identified in squamous cell lung cancer tumors helps personalize treatment

Screening lung cancer tumor samples for cancer-causing, or "driver," genetic mutations can help physicians tailor patients' treatments to target those specific mutations. While scientists have identified cancer-causing mutations ...

Cancer created May 17, 2012 | popularity not rated yet | comments 0